Valuation BLS Pharmaceuticals Limited

Stocks

Market Closed - Australian S.E. 01:10:29 2026-10-22 EDT			5-day change	1st Jan Change
0.9250 ^AUD	0.00%		-14.75%	+120.24%

09-21	BLS Pharmaceuticals Limited(ASX:BLS) added to S&P/ASX All Ordinaries Index	CI
09-13	BLS Pharmaceuticals Limited Announces Appointment of Angus Walker as Alternate Director to Edward Myer, Effective September 14, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026
Market Cap ¹	17.92	7.682	38.03	10.23	88.76	213.1
Change	-	-57.14%	395.11%	-73.09%	767.35%	140.05%
Enterprise Value (EV) ¹	16.32	5.514	34.75	9.916	82.62	208.2
Change	-	-66.22%	530.16%	-71.46%	733.27%	152%
P/E	-35x	-30x	-13.9x	-0.72x	17.8x	13.9x
PBR	9.53x	4.07x	2.51x	2.84x	7.15x	6.88x
PEG	-	0.6x	-0x	-0x	-0x	0x
Capitalization / Revenue	8.13x	3.09x	7.17x	1.06x	3.03x	2.88x
EV / Revenue	7.4x	2.22x	6.55x	1.03x	2.82x	2.82x
EV / EBITDA	-124x	-38.9x	-20.1x	-9.16x	15.3x	10.3x
EV / EBIT	-109x	-36.2x	-18.9x	-8.75x	16.2x	10.7x
EV / FCF	34.5x	12.4x	-63.8x	-3.81x	29.2x	-112x
FCF Yield	2.9%	8.05%	-1.57%	-26.3%	3.42%	-0.89%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.007999	-0.003999	-0.0144	-0.069	0.023	0.067
Distribution rate	-	-	-	-	-	-
Net sales ¹	2.204	2.485	5.305	9.643	29.28	73.91
EBITDA ¹	-0.132	-0.1416	-1.726	-1.082	5.402	20.13
EBIT ¹	-0.1497	-0.1525	-1.836	-1.133	5.099	19.55
Net income ¹	-0.4957	-0.2365	-1.94	-13.33	4.901	15.4
Net Debt ¹	-1.602	-2.168	-3.287	-0.3176	-6.134	-4.856
Reference price ²	0.2800	0.1200	0.2000	0.0500	0.4100	0.9300
Nbr of stocks (in thousands)	64,015	64,015	190,165	204,665	216,483	229,104
Announcement Date	9/30/21	9/30/22	9/29/23	9/30/24	9/30/25	8/31/26

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BLS PHARMACEUTICALS LIMITED	-	-	-	-	150M
ELI LILLY AND COMPANY	36.67x	13.07x	27.74x	0.54%	1,133B
JOHNSON & JOHNSON	37.73x	6.36x	17.89x	2.07%	621B
ABBVIE INC.	36.35x	8.36x	17.26x	2.41%	503B
ROCHE HOLDING AG	21.21x	5.12x	12.74x	2.55%	379B
MERCK & CO., INC.	109.25x	6.09x	26.14x	2.27%	370B
NOVARTIS AG	21.57x	5.62x	13.82x	2.84%	292B
ASTRAZENECA PLC	22.08x	4.46x	12.77x	1.98%	262B
AMGEN INC.	27.83x	7.14x	12.79x	2.3%	237B
GILEAD SCIENCES, INC.	-44.76x	6.88x	26.67x	2.15%	190B
Average	29.77x	7.01x	18.64x	2.12%	398.81B
Weighted average by Cap.	35.57x	8.27x	20.36x	1.81%